XML 48 R25.htm IDEA: XBRL DOCUMENT v3.19.2
Net Earnings (Loss) Per Common Share
 6 Months Ended
Jun. 30, 2019
Earnings Per Share [Abstract]  
Net Earnings (Loss) Per Common Share
Net Loss Per Common Share

The following table sets forth the computation of basic and diluted net loss per common share for the periods indicated.
(In thousands except per share data)
For the Three Months Ended June 30,
 
For the Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
Basic
 
 
 
 
 
 
 
Average common shares outstanding
33,749

 
33,169

 
33,527

 
33,040

 
 
 
 
 
 
 
 
Net loss
$
(12,717
)
 
$
(16,543
)
 
$
(26,603
)
 
$
(30,651
)
 
 
 
 
 
 
 
 
Net loss per common share
$
(0.38
)
 
$
(0.50
)
 
$
(0.79
)
 
$
(0.93
)
 
 
 
 
 
 
 
 
Diluted
 
 
 
 
 
 
 
Average common shares outstanding
33,749

 
33,169

 
33,527

 
33,040

Stock options and awards
15

 
827

 
12

 
827

Average common shares assuming dilution
33,764

 
33,996

 
33,539

 
33,867

 
 
 
 
 
 
 
 
Net loss
$
(12,717
)
 
$
(16,543
)
 
$
(26,603
)
 
$
(30,651
)
 
 
 
 
 
 
 
 
Net loss per common share *
$
(0.38
)
 
$
(0.50
)
 
$
(0.79
)
 
$
(0.93
)

________
* Net loss per common share assuming dilution calculated utilizing weighted average shares outstanding-basic for the periods in which there was a net loss.

At June 30, 2019, 326,799 shares associated with stock options were excluded from the average common shares assuming dilution for the three months ended June 30, 2019 as they were anti-dilutive. At June 30, 2019, the majority of the anti-dilutive shares were granted at an exercise price of $25.24, which was higher than the average fair market value price of $6.52 and $6.85 for the three and six months ended June 30, 2019, respectively.

At June 30, 2018, 329,315 shares associated with stock options were excluded from the average common shares assuming dilution for the three and six months ended June 30, 2018 as they were anti-dilutive. At June 30, 2018, the majority of the anti-dilutive shares were granted at an exercise price of $25.79, which was higher than the average fair market value price of $18.09 and $17.87 for the three and six months ended June 30, 2018, respectively.











For both the three and six months ended June 30, 2019 and June 30, 2018, respectively, no shares were included in the common shares assuming dilution related to the company's issued warrants as the average market price of the company stock for these periods did not exceed the strike price of the warrants.